Market Indices
Sector Heatmap
NAMS — NewAmsterdam Pharma Company N.V. Ordinary Shares
NasdaqNewAmsterdam Pharma Company N.V. Ordinary Shares
- O
- 23.06
- H
- 23.11
- L
- 21.44
- V
- 1.26M
NAMS — Latest News & Headlines
9 StoriesSeven new hires receive stock options to buy NewAmsterdam shares at $24.16 each. - Stock Titan
Seven new hires receive stock options to buy NewAmsterdam shares at $24.16 each. Stock Titan
How Investors May Respond To NewAmsterdam Pharma (NAMS) First Europe Drug Approval - Simply Wall Street
How Investors May Respond To NewAmsterdam Pharma (NAMS) First Europe Drug Approval Simply Wall Street
RBC Capital cuts NewAmsterdam Pharma stock price target on trial risk - Investing.com
RBC Capital cuts NewAmsterdam Pharma stock price target on trial risk Investing.com
Trading Systems Reacting to (NAMS) Volatility - Stock Traders Daily
Trading Systems Reacting to (NAMS) Volatility Stock Traders Daily
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance UK
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Yahoo Finance UK
After exercising options, Futurum sold 50,246 NewAmsterdam Pharma (NAMS) shares at an average $25.03. - Stock Titan
After exercising options, Futurum sold 50,246 NewAmsterdam Pharma (NAMS) shares at an average $25.03. Stock Titan
NewAmsterdam Pharma (NAMS) Following Trial Progress And EU Approval Is The Valuation Story Changing - Simply Wall Street
NewAmsterdam Pharma (NAMS) Following Trial Progress And EU Approval Is The Valuation Story Changing Simply Wall Street
A drug trial will study about 400 people with Alzheimer’s-related changes but no noticeable symptoms. - Stock Titan
A drug trial will study about 400 people with Alzheimer’s-related changes but no noticeable symptoms. Stock Titan
NAMS261218C00055000 interactive stock chart | NAMS Dec 2026 55.000 call stock - Yahoo Finance UK
NAMS261218C00055000 interactive stock chart | NAMS Dec 2026 55.000 call stock Yahoo Finance UK